PHARMACOPIA, INC. – Trademark Portfolio

Entity Type: 03

PHARMACOPIA, INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PHARMACOPIA and BETTER FOR YOU BATH + BODY. The owner is based in MILL VALLEY, CA.

42 Park Terrace

MILL VALLEY, CA 94941

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PHARMACOPIA, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does PHARMACOPIA, INC. have?

PHARMACOPIA, INC. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does PHARMACOPIA, INC. file in?

PHARMACOPIA, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are PHARMACOPIA, INC.'s most well-known trademarks?

PHARMACOPIA, INC.'s registered trademark portfolio includes well-known marks such as PHARMACOPIA and BETTER FOR YOU BATH + BODY. These are among 3 currently registered trademarks in the portfolio.

What is PHARMACOPIA, INC.'s trademark registration success rate?

PHARMACOPIA, INC. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.